Answers are grounded in this paper and cite their sources.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that may be associated not only with reproductive and metabolic disturbances but also with ocular surface abnormalities, particularly dry eye disease (DED). Current evidence indicates that women with PCOS may exhibit structural and functional alterations of the meibomian glands, including gland loss, ductal abnormalities, and impaired lipid secretion, potentially contributing to tear film instability. Reduced tear break-up time (TBUT) is consistently reported, whereas Schirmer test results are often preserved, suggesting a predominantly evaporative dry eye phenotype. Hormonal imbalance, particularly hyperandrogenism, may play a complex and incompletely understood role in ocular surface homeostasis and could contribute to gland dysfunction. Furthermore, insulin resistance may impair meibomian gland metabolism, promote oxidative stress, and accelerate glandular atrophy. Chronic low-grade systemic inflammation has also been implicated and may further exacerbate ocular surface damage. The interaction of hormonal, metabolic, and inflammatory factors may increase the risk of DED in women with PCOS; however, the available evidence remains limited and heterogeneous. Further well-designed studies are required to clarify underlying mechanisms and support the development of targeted multidisciplinary management strategies.
No takes yet. Share an insight, caveat, or question.
Bomze et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: